We’re very proud of Klara’s study, in collaboration with the University Hospital Zurich, now out in Nature Cancer. See also the Research Briefing providing background and comments.
We have followed and analyzed biopsies of a cohort of patients suffering from Multiple Myeloma over several years. Combined pharmacoscopy testing with proteotyping by the Wollscheid Lab reveals the molecular network underlying drug resistance, and shows that pharmacoscopy identifies effective personalized treatments for this complex cancer.
With generous funding from the European Research Council!
Additional reading:
– ETH News post: “How can we fight blood cancer more effectively?“
– MedicalXPress.com: “Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma“